We serve Chemical Name:2,2-Dibromo-2-cyanoacetamide CAS:10222-01-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,2-Dibromo-2-cyanoacetamide
CAS.NO:10222-01-2
Synonyms:2,2-Dibromo-3-nitrilopropionamide;Cyanodibromoacetamide;3-02-00-01641;EINECS 233-539-7;MFCD00129791;Dbnpa;ZVXEECN;Acetamide, 2,2-dibromo-2-cyano-;Dibromocyano acetic acid amide;dibromocyanoacetamide;2,2-Dibromo-2-cyanoacetamide;2-Cyano-2,2-dibromoacetamide;3-02-00-01641 (Beilstein Handbook Reference);2,2-Dibromo-2-carbamoylacetonitrile
Molecular Formula:C3H2Br2N2O
Molecular Weight:241.869
HS Code:2926909090
Physical and Chemical Properties:
Melting point:122-125 °C(lit.)
Boiling point:221.5±40.0 °C at 760 mmHg
Density:2.5±0.1 g/cm3
Index of Refraction:1.625
PSA:66.88000
Exact Mass:239.853378
LogP:1.51
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1759 8/PG 3
Packing Group:III
Contact us for information like 2,2-Dibromo-3-nitrilopropionamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2-Dibromo-2-carbamoylacetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dibromocyano acetic acid amide Use and application,2,2-Dibromo-2-carbamoylacetonitrile technical grade,usp/ep/jp grade.
Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships. 2,2-Dibromo-2-cyanoacetamide manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 2,2-Dibromo-2-cyanoacetamide supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 2,2-Dibromo-2-cyanoacetamide vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. 2,2-Dibromo-2-cyanoacetamide factory Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.
